Triage Survey for Psychiatry Research Eligibility

Major Depressive Disorder Clinical Trial

— TRIAGE-Psych  

Official title:

Triage Survey for Psychiatry Research Eligibility

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05800925
• Other study ID #: TRIAGE-Psych-101
• Status: Recruiting
• Start date: December 21, 2021
• Est. completion date: December 31, 2025

Study information

• Verified date: October 2023
• Source: Adams Clinical
• Contact: Miriam Evans, PhD
• Phone: 617-744-8542
• Email: mevans[@]adamsclinical.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: December 31, 2025
• Est. primary completion date: December 31, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
• Participant is at least 18 years old.

Exclusion Criteria:

• Participant is pregnant, breast-feeding, or planning to become pregnant.
• History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
• Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
• Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
• Any condition that in the investigator's opinion makes a participant unsuitable for the study.
• Currently employed by Adams Clinical or a first-degree relative of an employee.

Related Conditions & MeSH terms

• Anxiety Disorders
• Borderline Personality Disorder
• Depressive Disorder
• Depressive Disorder, Major
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Personality Disorders

Intervention

Other:
• Survey
Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.

Locations

Country	Name	City	State
United States	Copley Clinical	Boston	Massachusetts
United States	Berman Clinical	New York	New York
United States	Adams Clinical	Watertown	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Adams Clinical

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study		Up to 52 weeks
Secondary	The proportion of participants who enroll in industry-sponsored clinical trials		Up to 52 weeks
Secondary	The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials		Up to 52 weeks